ResMed Inc (RMD)

Pretax margin

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Earnings before tax but after interest (EBT) (ttm)	US$ in thousands	1,264,798	1,183,868	1,097,825	1,112,062	1,101,664	1,062,951	999,892	963,487	960,482	961,604	953,290	926,596	883,662	856,545	830,195	798,355	733,088	616,759	563,033	530,554
Revenue (ttm)	US$ in thousands	4,681,240	4,528,920	4,442,900	4,314,610	4,171,410	4,064,591	3,819,396	3,688,938	3,645,890	3,606,884	3,513,684	3,419,445	3,265,514	3,144,973	3,128,793	3,045,837	2,957,056	2,891,676	2,784,449	2,699,392
Pretax margin		27.02%	26.14%	24.71%	25.77%	26.41%	26.15%	26.18%	26.12%	26.34%	26.66%	27.13%	27.10%	27.06%	27.24%	26.53%	26.21%	24.79%	21.33%	20.22%	19.65%

June 30, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $1,264,798K ÷ $4,681,240K
= 27.02%

The pretax margin of ResMed Inc has shown relatively stable performance over the past several quarters, ranging from 19.65% to 27.24%. This metric measures the efficiency of the company in generating profits before taxes relative to its total revenue. The company has maintained a healthy pretax margin above 20% in most reporting periods, indicating effective cost management and operational efficiency.

In the most recent quarter, the pretax margin was 27.02%, which reflects the company's ability to control expenses and generate strong earnings. The consistency of pretax margins above 20% suggests that ResMed Inc has been able to maintain profitability even in challenging economic conditions. Overall, the pretax margin trend indicates that the company has been effectively managing its costs and operating efficiently to drive sustainable profitability.